Abstract: An organoluminescent compound. The compound has formula (I) wherein X1 and X2 independently represent C10-25 aryl, heteroaryl, stilbenyl, silylaryl, or arylsilyl; n represents an integer of 0 to 2; L represents aryl or heteroaryl; and A1, A2, and A3 independently represent aryl or heteroaryl. The invention also provides an organic light-emitting diode and a display utilizing the organoluminescent compound.

Abstract: A light-emitting material is represented by the following general formula [1]: useful as an emissive layer of organic electroluminescent device (OELD). The chemical structure L is selected from a group consisting of the chemical structures AA, BB, AB, and the combination thereof. The chemical structures A and B are respectively represented by the following general formulas [2] and [3]: The chemical structure X is selected from the group 4A to 6A elements of the periodic table. The chemical structure B is an aromatic hydrocarbon having n benzenes, wherein n is an integer of 1 to 8.

Abstract: This invention relates to compounds of the following formula: in which R1, R2, A1, A2, X, Y, m, n, p, x and y are as defined herein, pharmaceutical compositions comprising the compounds and use of the compounds in treating enterovirus infection.

Abstract: This invention relates to pyrazole compounds of formula (I) shown below: Each variable in formula (I) is defined in the specification. These compounds can be used to treat cannabinoid-receptor mediated disorders.

Abstract: This invention relates to thiophene compounds of formula (I) shown below: Each variable in formula (I) is defined in the specification. These compounds can be used to treat cannabinoid-receptor mediated disorders.

Abstract: In an OLED having an electron transport layer and a light emitting layer, at least one of these layers contains an anthracene derivative, wherein at least one of the substituents on the anthracene compound has a tetra-substitution center of either C—SP3 or Si. The anthracene derivative can be used as dopant or host material in the light-emitting layer.

Abstract: This invention is about anthracene, at least one having silyl substituted group on ring 9 and 10, the anthracene can be a organic light emitting diodes (OLED) material and used for organic electroluminescent device. wherein X is an triarylsilyl group having 6 to 20 carbon atoms, an trialkylsilyl group having 1 to 12 carbon atoms, a substituted or unsubstituted aryl group having 6 to 20 carbon atoms, a substituted or unsubstituted heteroaryl group having 2 to 20 carbon atoms, or a substituted or unsubstituted alkyl group having 1 to 12 carbon atoms. R1 and R2 is independently a hydrogen, halogen, or a substituted or unsubstituted alkyl group having 1 to 12 carbon atoms. R3 to R5 is independently a substituted or unsubstituted aryl group having 6 to 20 carbon atoms, or a substituted or unsubstituted alkyl group having 1 to 12 carbon atoms.

Abstract: This invention relates to thiophene compounds of formula (I) shown below: Each variable in formula (I) is defined in the specification. These compounds can be used to treat cannabinoid-receptor mediated disorders.

Abstract: This invention relates to pyrazole compounds of formula (I) shown below: Each variable in formula (I) is defined in the specification. These compounds can be used to treat cannabinoid-receptor mediated disorders.

Abstract: This invention relates to selenophene compounds of formula (I) shown below. Each variable in formula (I) is defined in the specification. These compounds can be used to treat cannabinoid-receptor mediated disorders.

Abstract: This invention is about anthracene, at least one having silyl substituted group on ring 9 and 10, the anthracene can be a organic light emitting diodes (OLED) material and used for organic electroluminescent device. wherein X is an triarylsilyl group having 6 to 20 carbon atoms, an trialkylsilyl group having 1 to 12 carbon atoms, a substituted or unsubstituted aryl group having 6 to 20 carbon atoms, a substituted or unsubstituted heteroaryl group having 2 to 20 carbon atoms, or a substituted or unsubstituted alkyl group having 1 to 12 carbon atoms. R1 and R2 is independently a hydrogen, halogen, or a substituted or unsubstituted alkyl group having 1 to 12 carbon atoms. R3 to R5 is independently a substituted or unsubstituted aryl group having 6 to 20 carbon atoms, or a substituted or unsubstituted alkyl group having 1 to 12 carbon atoms.

Abstract: This invention is about anthracene, at least one having silyl substituted group on ring 9 and 10, the anthracene can be a organic light emitting diodes (OLED) material and used for organic electroluminescent device. wherein X is an triarylsilyl group having 6 to 20 carbon atoms, an trialkylsilyl group having 1 to 12 carbon atoms, a substituted or unsubstituted aryl group having 6 to 20 carbon atoms, a substituted or unsubstituted heteroaryl group having 2 to 20 carbon atoms, or a substituted or unsubstituted alkyl group having 1 to 12 carbon atoms. R1 and R2 is independently a hydrogen, halogen, or a substituted or unsubstituted alkyl group having 1 to 12 carbon atoms. R3 to R5 is independently a substituted or unsubstituted aryl group having 6 to 20 carbon atoms, or a substituted or unsubstituted alkyl group having 1 to 12 carbon atoms.

Abstract: This invention relates to compounds of the following formula: in which R1, R2, A1, A2, X, Y, m, n, p, x and y are as defined herein, pharmaceutical compositions comprising the compounds and use of the compounds in treating enterovirus infection.

Abstract: In an OLED having an electron transport layer and a light emitting layer, at least one of these layers contains an anthracene derivative, wherein at least one of the substituents on the anthracene compound has a tetra-substitution center of either C—SP3 or Si. The anthracene derivative can be used as dopant or host material in the light-emitting layer.

Abstract: This invention relates to compounds of the following formula: in which R1, R2, A1, A2, X, Y, m, n, p, x and y are as defined herein, pharmaceutical compositions comprising the compounds and use of the compounds in treating enterovirus infection.

Abstract: An organic electroluminescent device (OELD) is provided. The OELD includes a substrate, an anode, a cathode and an emissive layer. The anode and the cathode opposite to the anode are disposed over the substrate. The emissive layer is disposed between the anode and the cathode. The emissive layer includes a light-emitting material. The chemical structure of the light-emitting material represented by the formula [1]: The chemically structure L is selected from a group consisting of the chemical structures AA, BB, AB, and the combination thereof. The chemical structure A of the formula [2]: The chemical structure X is selected from the group 4A to 6A elements of the periodic table. The chemical structure B is aromatic hydrocarbons having n benzene, n is a integer of 1 to 8.

Abstract: This invention is about anthracene, at least one having silyl substituted group on ring 9 and 10, the anthracene can be a organic light emitting diodes(OLED) material and used for organic electroluminescent device. wherein X is an triarylsilyl group having 6 to 20 carbon atoms, an trialkylsilyl group having 1 to 12 carbon atoms, a substituted or unsubsituted aryl group having 6 to 20 carbon atoms, a substituted or unsubsituted heteroaryl group having 2 to 20 carbon atoms, or a substituted or unsubsituted alkyl group having 1 to 12 carbon atoms. R1 and R2 is independently a hydrogen, halogen, or a substituted or unsubsituted alkyl group having 1 to 12 carbon atoms. R3 to R5 is independently a substituted or unsubsituted aryl group having 6 to 20 carbon atoms, or a substituted or unsubsituted alkyl group having 1 to 12 carbon atoms.

Abstract: A method for synthesizing a clock signal with multiple frequency outputs for use in a converter for converting a non-interlacing scan data into an interlacing scan data is disclosed. The converter provides a first reference clock signal with a frequency F1. The method includes the steps of receiving the first reference clock signal with the frequency F1 to generate and output a clock signal with a frequency F1×N, proceeding a divided-by-P1 and a divided-by-P2 operations on the clock signal with a frequency F1×N, respectively, to output a first output clock signal with a frequency F1×N/P1 and a second output clock signal with a frequency F1×N/P2, respectively. The value P2/P1 correlates to a ratio of the pixel number of a horizontal scan line in the non-interlacing scan data to that in the interlacing scan data. In addition, a clock signal synthesizer with multiple frequency outputs is also disclosed.

Abstract: An organoluminescent compound. The compound has formula (I) wherein X1 and X2 independently represent C10-25 aryl, heteroaryl, stilbenyl, silylaryl, or arylsilyl; n represents an integer of 0 to 2; L represents aryl or heteroaryl; and A1, A2, and A3 independently represent aryl or heteroaryl. The invention also provides an organic light-emitting diode and a display utilizing the organoluminescent compound.

Abstract: A method for processing an image to convert a non-interlacing scan data into an interlacing scan data is disclosed. The method includes the steps of receiving a non-interlacing scan data, the non-interlacing scan data including plural pixels, replacing a color space value of a selected one of the pixels in the non-interlacing scan data with a combination of color space values of the selected one pixel and at least one adjacent pixel to obtain a blurringly filtered non-interlacing scan data, scaling the blurringly filtered non-interlacing scan data according to a specific algorithm, and converting the blurringly filtered non-interlacing scan data into an interlacing scan data. An image-processing device for converting a non-interlacing scan data into an interlacing scan data is also disclosed. The device includes a blurring filter, a scaler and a converter.